Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-027625
Filing Date
2023-03-02
Accepted
2023-03-02 07:01:09
Documents
1
Period of Report
2023-03-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm237858-3_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm237858-3_4seq1.xml 4 4301
  Complete submission text file 0001104659-23-027625.txt   5687
Mailing Address 314 MAIN STREET, SUITE 04-200 CAMBRIDGE MA 02142
Business Address 314 MAIN STREET, SUITE 04-200 CAMBRIDGE MA 02142 (857) 400-9491
Theseus Pharmaceuticals, Inc. (Issuer) CIK: 0001745020 (see all company filings)

EIN.: 830712806 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1/3 HIGH-TECH VILLAGE GIVAT RAM, P.O. BOX 39264 JERUSALEM L3 9139102
Business Address
Kerstein David (Reporting) CIK: 0001796388 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40869 | Film No.: 23696371